Skip to main content

AES CORP

For the period ended Dec 31, 2025. Filed Mar 2, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 2, 2026

AES$14.90+0.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

THE AES CORPORATION(Company)
Date:March 2, 2026By:/s/ ANDRÉS GLUSKI
Name:Andrés Gluski
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.

NameTitleDate
*Chief Executive Officer (Principal Executive Officer) and Director
Andrés GluskiMarch 2, 2026
*Director
Gerard M. AndersonMarch 2, 2026
*Director
Inderpal S. BhandariMarch 2, 2026
*Director
Janet G. DavidsonMarch 2, 2026
*Director
Holly K. KoeppelMarch 2, 2026
*Director
Julia M. LaulisMarch 2, 2026
*Director
Alain MoniéMarch 2, 2026
*Chairman of the Board and Lead Independent Director
John B. MorseMarch 2, 2026
*Director
Moisés NaímMarch 2, 2026
*Director
Teresa M. SebastianMarch 2, 2026
*Director
Maura ShaughnessyMarch 2, 2026
/s/ STEPHEN COUGHLINExecutive Vice President and Chief Financial Officer (Principal Financial Officer)
Stephen CoughlinMarch 2, 2026
/s/ SHERRY L. KOHANSenior Vice President and Chief Accounting Officer (Principal Accounting Officer)
Sherry L. KohanMarch 2, 2026
*By:/s/ PAUL L. FREEDMANMarch 2, 2026
Attorney-in-fact
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.